Who have Retroperitoneal haemorrhage with Meropenem - from FDA reports


Retroperitoneal haemorrhage is reported only by a few people who take Meropenem. We study 11,933 people who have side effects while taking Meropenem from FDA. Among them, 4 have Retroperitoneal haemorrhage. Find out below who they are, when they have Retroperitoneal haemorrhage and more.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Dec, 06, 2018

11,933 people reported to have side effects when taking Meropenem.
Among them, 4 people (0.03%) have Retroperitoneal haemorrhage


Number of reports submitted per year:

Could Meropenem cause Retroperitoneal haemorrhage?

Gender of people who have Retroperitoneal haemorrhage when taking Meropenem *:

  • female: 75 %
  • male: 25 %

Age of people who have Retroperitoneal haemorrhage when taking Meropenem *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  1. Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 25.00%
  2. Preventive Health Care: 1 person, 25.00%
  3. Pneumonia: 1 person, 25.00%
  4. Paroxysmal Supraventricular Tachycardia: 1 person, 25.00%
  5. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 1 person, 25.00%

Click here to view more results or personalize the results to your gender and age

Top co-used drugs for these people *:

  1. Aspirin: 2 people, 50.00%
  2. Lasix: 1 person, 25.00%
  3. Colace: 1 person, 25.00%
  4. Crestor: 1 person, 25.00%
  5. Cubicin: 1 person, 25.00%

Click here to view more results or personalize the results to your gender and age

Top other side effects for these people *:

  1. Haemoglobin Decreased: 2 people, 50.00%
  2. Sick Sinus Syndrome (a collection of heart rhythm disorders): 1 person, 25.00%
  3. Shock Haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding): 1 person, 25.00%
  4. Post Procedural Complication: 1 person, 25.00%
  5. International Normalised Ratio Increased: 1 person, 25.00%

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Do you have Retroperitoneal haemorrhage while taking Meropenem?


You are not alone:




Related studies

Meropenem

Meropenem has active ingredients of meropenem. (latest outcomes from Meropenem 11,971 users)

Retroperitoneal haemorrhage

Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall) has been reported by people with atrial fibrillation/flutter, stroke, deep venous thrombosis, pulmonary embolism, high blood pressure (latest reports from 3,053 Retroperitoneal haemorrhage patients).


Drugs that are associated with Retroperitoneal haemorrhage
Retroperitoneal haemorrhage (577 drugs)
Could your condition cause Retroperitoneal haemorrhage
Retroperitoneal haemorrhage (310 conditions)
Meropenem side effects
Browse all side effects of Meropenem
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


What would happen?

Predict new side effects and undetected conditions when you take Meropenem and have Retroperitoneal haemorrhage


Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!